0000318989-18-000018.txt : 20180405 0000318989-18-000018.hdr.sgml : 20180405 20180405122839 ACCESSION NUMBER: 0000318989-18-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180403 FILED AS OF DATE: 20180405 DATE AS OF CHANGE: 20180405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FIL Ltd CENTRAL INDEX KEY: 0000318989 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38443 FILM NUMBER: 18739905 BUSINESS ADDRESS: STREET 1: P.O. BOX H.M. 670 CITY: HAMILTON STATE: D0 ZIP: 00000 BUSINESS PHONE: 6175637100 MAIL ADDRESS: STREET 1: P.O. BOX H.M. 670 CITY: HAMILTON STATE: D0 ZIP: 00000 FORMER NAME: FORMER CONFORMED NAME: FIL LTD DATE OF NAME CHANGE: 20080213 FORMER NAME: FORMER CONFORMED NAME: FIDELITY INTERNATIONAL LTD DATE OF NAME CHANGE: 19920929 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unum Therapeutics Inc. CENTRAL INDEX KEY: 0001622229 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465308248 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CAMBRIDGE PARK DRIVE STREET 2: SUITE 3100 CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-945-5576 MAIL ADDRESS: STREET 1: 200 CAMBRIDGE PARK DRIVE STREET 2: SUITE 3100 CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: Unum Therapeutics, Inc. DATE OF NAME CHANGE: 20141014 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-04-03 1 0001622229 Unum Therapeutics Inc. UMRX 0000318989 FIL Ltd P.O. BOX H.M. 670 HAMILTON D0 00000 BERMUDA 0 0 0 1 See Remark 1 Common Stock 2018-04-03 4 C 0 1110932 A 1110932 D Common Stock 2018-04-03 4 C 0 27342 A 1138274 D Series A Preferred Stock 2018-04-03 4 C 0 1744310 D Common Stock 1110932 0 D Series B Preferred Stock 2018-04-03 4 C 0 42931 D Common Stock 27342 0 D On April 3, 2018, in connection with the completion of the issuer's initial public offering, each 1.5701314513884 shares of Series A and Series B Preferred Stock converted into 1 share of Common Stock. Remark 1: Pandanus Partners, L.P. ("Pandanus") owns shares of FIL Limited ("FIL") voting stock. While the percentage of total voting power represented by these shares of FIL voting stock may fluctuate as a result of changes in the total number of shares of FIL voting stock outstanding from time to time, it normally represents more than 25% and less than 48.5% of the total votes which may be cast by all holders of FIL voting stock. Pandanus Associates, Inc. ("PAI") acts as general partner of Pandanus. Pandanus is owned by trusts for the benefit of members of the Johnson family, including FIL's Chairman Abigail P. Johnson, but disclaims that any such member is a beneficial owner of the securities reported on this form. The address of Pandanus is c/o FIL Limited, 42 Crow Lane, Hamilton, Bermuda, HM19. The address of PAI is 11 Keewaydin Drive, Suite 100, Salem, NH, USA, 03079. Marc R. Bryant, Duly authorized under Powers of Attorney effective as of September 16, 2015, by and on behalf of FIL Limited and its direct and indirect subsidiaries, Pandanus Partners, L.P. and Pandanus Associates, Inc. 2018-04-04